Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Braskem (BAK) Accounts Payables (2016 - 2025)

Braskem has reported Accounts Payables over the past 17 years, most recently at $2.4 billion for Q4 2025.

  • For Q4 2025, Accounts Payables fell 15.87% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, down 15.87%, while the annual FY2025 figure was $2.4 billion, 15.87% down from the prior year.
  • Accounts Payables for Q4 2025 was $2.4 billion at Braskem, up from $316.4 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $3.2 billion in Q2 2024 and troughed at $129.2 million in Q2 2023.
  • A 5-year average of $2.0 billion and a median of $2.3 billion in 2022 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: surged 2367.33% in 2024 and later fell 15.87% in 2025.
  • Year by year, Accounts Payables stood at $2.2 billion in 2021, then grew by 7.73% to $2.3 billion in 2022, then grew by 14.72% to $2.7 billion in 2023, then increased by 8.78% to $2.9 billion in 2024, then decreased by 15.87% to $2.4 billion in 2025.
  • Business Quant data shows Accounts Payables for BAK at $2.4 billion in Q4 2025, $316.4 million in Q1 2025, and $2.9 billion in Q4 2024.